China To Opt For Infection, Tumor, Digestion Drugs In Pilot Uniform Pricing
This article was originally published in PharmAsia News
Executive Summary
China is likely to launch details of its uniform generic evaluations and pilot them first on commonly used drugs, including infectious, anti-tumor, and digestive, according to participating sources.